Updates

Krsnaa Diagnostics delivered strong Q2 FY26 results: Revenue up 11% to 206 Cr, EBITDA up 18% to 60.2 Cr, and record PAT of 23.9 Cr, up 22%. Retail revenue contribution surged from 1% to 8%. The company is expanding its radiology and pathology network.